|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen J, Chen Y and Chen Z: MiR-125a/b
regulates the activation of cancer stem cells in
paclitaxel-resistant colon cancer. Cancer Invest. 31:17–23. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nie J, Liu L, Xing G, Zhang M, Wei R, Guo
M, Li X, Xie P, Li L, He F, et al: CKIP-1 acts as a colonic tumor
suppressor by repressing oncogenic Smurf1 synthesis and promoting
Smurf1 autodegradation. Oncogene. 33:3677–3687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Faltejskova P, Svoboda M, Srutova K,
Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K,
Kiss I, et al: Identification and functional screening of microRNAs
highly deregulated in colorectal cancer. J Cell Mol Med.
16:2655–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hüttenhofer A, Schattner P and Polacek N:
Non-coding RNAs: Hope or hype? Trends Genet. 21:289–297. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: MicroRNA pathways in flies and
worms: Growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carlsson J, Davidsson S, Helenius G,
Karlsson M, Lubovac Z, Andrén O, Olsson B and Klinga-Levan K: A
miRNA expression signature that separates between normal and
malignant prostate tissues. Cancer Cell Int. 11:142011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Caldas C and Brenton JD: Sizing up miRNAs
as cancer genes. Nat Med. 11:712–714. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Luo Q, Li X, Gao Y, Long Y, Chen L, Huang
Y and Fang L: MiRNA-497 regulates cell growth and invasion by
targeting cyclin E1 in breast cancer. Cancer Cell Int. 13:952013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao WY, Wang Y, An ZJ, Shi CG, Zhu GA,
Wang B, Lu MY, Pan CK and Chen P: Downregulation of miR-497
promotes tumor growth and angiogenesis by targeting HDGF in
non-small cell lung cancer. Biochem Biophys Res Commu. 435:466–471.
2013. View Article : Google Scholar
|
|
16
|
Guo ST, Jiang CC, Wang GP, Li YP, Wang CY,
Guo XY, Yang RH, Feng Y, Wang FH, Tseng HY, et al: MicroRNA-497
targets insulin-like growth factor 1 receptor and has a tumour
suppressive role in human colorectal cancer. Oncogene.
32:1910–1920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu W, Zhu D, Lu S, Wang T, Wang J, Jiang
B, Shu Y and Liu P: miR-497 modulates multidrug resistance of human
cancer cell lines by targeting BCL2. Med Oncol. 29:384–391. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Y, Meng Q, Qi J, Shen H and Sun S:
MiR-497 promotes metastasis of colorectal cancer cells through
Nrdp1 inhibition. Tumour Biol. 36:7641–7647. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Wu A, Sun H, Drakas R, Garofalo C,
Cascio S, Surmacz E and Baserga R: Functional significance of type
1 insulin-like growth factor-mediated nuclear translocation of the
insulin receptor substrate-1 and beta-catenin. J Biol Chem.
280:29912–29920. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu A, Chen J and Baserga R: Nuclear
insulin receptor substrate-1 activates promoters of cell cycle
progression genes. Oncogene. 27:397–403. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bergmann U, Funatomi H, Kornmann M, Beger
HG and Korc M: Increased expression of insulin receptor substrate-1
in human pancreatic cancer. Biochem Biophys Res Commun.
220:886–890. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang Q, Li Y, White MF, Fletcher JA and
Xiao S: Constitutive activation of insulin receptor substrate 1 is
a frequent event in human tumors: Therapeutic implications. Cancer
Res. 62:6035–6038. 2002.PubMed/NCBI
|
|
23
|
Slattery ML, Samowitz W, Curtin K, Ma KN,
Hoffman M, Caan B and Neuhausen S: Associations among IRS1, IRS2,
IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Cancer Epidemiol Biomarkers Prev. 13:1206–1214. 2004.PubMed/NCBI
|
|
24
|
Fléjou JF: WHO classification of digestive
tumors: The fourth edition. Ann Pathol. 31:S27–31. 2011.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi ZM, Wang XF, Qian X, Tao T, Wang L,
Chen QD, Wang XR, Cao L, Wang YY, Zhang JX, et al: MiRNA-181b
suppresses IGF-1R and functions as a tumor suppressor gene in
gliomas. RNA. 19:552–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peterson SM, Thompson JA, Ufkin ML,
Sathyanarayana P, Liaw L and Congdon CB: Common features of
microRNA target prediction tools. Front Genet. 5:232014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi Z, Chen Q, Li C, Wang L, Qian X, Jiang
C, Liu X, Wang X, Li H, Kang C, Jiang T, Liu L, You Y, Liu N and
Jiang B: MiR-124 governs glioma growth and angiogenesis and
enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro
Oncol. 16:1341–1353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu J, Wang T, Cao Z, Huang H, Li J, Liu W,
Liu S, You L, Zhou L, Zhang T and Zhao Y: MiR-497 downregulation
contributes to the malignancy of pancreatic cancer and associates
with a poor prognosis. Oncotarget. 5:6983–6993. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Majid S, Dar AA, Saini S, Deng G, Chang I,
Greene K, Tanaka Y, Dahiya R and Yamamura S: MicroRNA-23b functions
as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS
One. 8:e676862013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang KY, Ma J, Zhang FX, Yu MJ, Xue JS and
Zhao JS: MicroRNA-378 inhibits cell growth and enhances
L-OHP-induced apoptosis in human colorectal cancer. IUBMB Life.
66:645–654. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhao HJ, Ren LL, Wang ZH, Sun TT, Yu YN,
Wang YC, Yan TT, Zou W, He J, Zhang Y, et al: MiR-194 deregulation
contributes to colorectal carcinogenesis via targeting AKT2
pathway. Theranostics. 4:1193–1208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han J, Huo M, Mu M, Liu J and Zhang J:
miR-497 suppresses proliferation of human cervical carcinoma HeLa
cells by targeting cyclin E1. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
30:597–600. 2014.(In Chinese). PubMed/NCBI
|
|
34
|
Scharf JG and Braulke T: The role of the
IGF axis in hepatocarcinogenesis. Horm Metab Res. 35:685–693. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scharf JG, Dombrowski F and Ramadori G:
The IGF axis and hepatocarcinogenesis. Mol Pathol. 54:138–144.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang LM, Myers MG Jr, Sun XJ, Aaronson SA,
White M and Pierce JH: IRS-1: Essential for insulin- and
iL-4-stimulated mitogenesis in hematopoietic cells. Science.
261:1591–1594. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taouis M, Dupont J, Gillet A, Derouet M
and Simon J: Insulin receptor substrate 1 antisense expression in
an hepatoma cell line reduces cell proliferation and induces
overexpression of the Src homology 2 domain and collagen protein
(SHC). Mol Cell Endocrinol. 137:177–186. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Waters SB, Yamauchi K and Pessin JE:
Functional expression of insulin receptor substrate-1 is required
for insulin-stimulated mitogenic signaling. J Biol Chem.
268:22231–22234. 1993.PubMed/NCBI
|
